PTGS2 and hepatocellular carcinoma: None of the studies included in our meta-analysis is not retrospective hospital-based case-control study and thus a prospective study should be applied to study the causal relationship between three COX-2 polymorphisms (-1195G/A,-765G/C and +8473T/C) and HCC risk.